- Previous Close
0.0440 - Open
0.0440 - Bid 0.0310 x --
- Ask 0.0430 x --
- Day's Range
0.0440 - 0.0440 - 52 Week Range
0.0190 - 0.0640 - Volume
1,000 - Avg. Volume
3,924 - Market Cap (intraday)
6.43M - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Aug 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date May 5, 2021
- 1y Target Est
--
Asia Vets Holdings Ltd., through its subsidiary, AVH Animal Ark Pte. Ltd., provides veterinary care and clinical services to small animals in Singapore. The company operates two veterinary clinics, which provides general veterinary services including medical, surgical, and dental care for small animals, such as dogs, cats, rabbits, hamsters, guinea pigs, and chinchillas. It also provides vaccination, health check, dentistry, acupuncture, and traditional Chinese medicines; and natural killer cell and stem cell therapies, in-house blood tests, such as biochemistry and hematology, interventional radiology and endoscopy, surgery and invasive procedures, and pet diet prescription services, as well as diagnostic imaging, which includes ultrasonography, digital radiography, laparoscopy, and endoscopy. Asia Vets Holdings Ltd. was formerly known as Smartflex Holdings Ltd. and changed its name to Asia Vets Holdings Ltd. in July 2018. The company was incorporated in 2010 and is headquartered in Singapore. Asia Vets Holdings Ltd. operates as a subsidiary of Tan Gee Beng Pte. Ltd.
www.asiavets.com19
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 5RE.SI
View MorePerformance Overview: 5RE.SI
Trailing total returns as of 9/30/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 5RE.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 5RE.SI
View MoreValuation Measures
Market Cap
6.43M
Enterprise Value
-2.11M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.51
Price/Book (mrq)
0.36
Enterprise Value/Revenue
-1.81
Enterprise Value/EBITDA
12.65
Financial Highlights
Profitability and Income Statement
Profit Margin
-25.42%
Return on Assets (ttm)
-2.52%
Return on Equity (ttm)
-3.62%
Revenue (ttm)
2.56M
Net Income Avi to Common (ttm)
-651.29k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
8.6M
Total Debt/Equity (mrq)
0.31%
Levered Free Cash Flow (ttm)
-527.13k